Pfizer PFE Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 293.4%+23.2pp | 292.1%+36.2pp | 289.7%+47.6pp | 284.1%+48.3pp | 270.1%+22.6pp | |
| Efficiency | ||||||
| Asset turnover | 1.2×+0.1× | 1.2×+0.1× | 1.2×+0.1× | 1.2×0.0× | 1.1×-0.2× | |
| Liquidity | ||||||
| Current ratio | 4.8×+0.6× | 4.9×+0.8× | 4.9×+1.1× | 4.6×-0.6× | 4.3×-2.2× | |
| Leverage | ||||||
| Debt-to-equity | 2.9×+0.1× | 2.8×+0.1× | 2.8×0.0× | 2.8×0.0× | 2.8×0.0× | |
| Per Share | ||||||
| Book value per share | $62.64-0.4% | $62.74-0.8% | $63.08-0.4% | $63.02-2.1% | $62.87-5.2% | |
| Valuation | ||||||
| Market capitalization | $584.38B-5.2% | $568.37B-9.7% | $577.14B-10.1% | $596.25B-10.4% | $616.32B-13.7% | |
| Price / sales | 9.3×-0.9× | 9×-1.7× | 9.1×-1.9× | 9.5×-1.5× | 10.2×-0.6× | |
| Price / book | 6.5×-0.3× | 6.3×-0.6× | 6.4×-0.7× | 6.6×-0.6× | 6.9×-0.7× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Pfizer's ratios come from?
- Every ratio is computed from Pfizer's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
